Reflections on the 50th annual meeting of the EASD

Authors

  • Mike Gwilt

DOI:

https://doi.org/10.15277/bjdvd.2014.050

References

50th Annual Meeting of the European Association for the Study of Diabetes, Vienna, Austria, 13–19 September, 2014. See www.easd.org

Bailey CJ et al. Metformin – the Gold Standard: A Scientific Handbook, 2007, Wiley (ISBN 978-0-470-72541-2).

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854-65. http://dx.doi.org/10.1016/S0140-6736(98)07037-8

Kooy A, de Jager J, Lehert P, et al. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus. Arch Intern Med 2009;169:616-25. http://dx.doi.org/10.1001/archinternmed.2009.20

Glucose Lowering in Non-Diabetic Hyperglycaemia Trial. See www.dtu.ox.ac.uk/glint

Holman RR, Paul SK, Bethal MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359: 1577-89. http://dx.doi.org/10.1056/NEJMoa0806470

Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New Engl J Med 2005;353:2643-53. http://dx.doi.org/10.1056/NEJMoa052187

Holman RR, Paul SK, Bethel MA, et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008;359:1565-76. http://dx.doi.org/10.1056/NEJMoa0806359

Downloads

Published

2014-11-24

Issue

Section

Meeting Reports